Author:
Shilpi Satish,Gurnany Ekta,Gupta Pawan K.,Sharma Kangan,Saini Khyati,Chimaniya Pranali,Bhatt Shvetank
Publisher
Springer Nature Singapore
Reference81 articles.
1. Akram MS, Pery N, Butler L, Shafiq MI, Batool N, Rehman MF, Grahame-Dunn LG, Yetisen AK (2021) Challenges for biosimilars: focus on rheumatoid arthritis. Crit Rev Biotechnol 41(1):121–153
2. American Society of Clinical Oncology (ASCO) (2018) ASCO position statement on Biosimilars in oncology. J Clin Oncol 36(12):1260–1265. https://doi.org/10.1200/JCO.2017.77.4893
3. Bachu RD, Abou-Dahech M, Balaji S, Boddu SHS, Amos S, Singh V, Babu RJ, Tiwari AK (2022) Oncology biosimilars: New developments and future directions. Cancer Rep (Hoboken) 5(11):e1720. https://doi.org/10.1002/cnr2.1720. Epub 2022 Oct 4
4. Biosimilars Info Sheet (n.d.) Generics and biosimilars. https://www.fda.gov/media/154912/download
5. Blackstone EA, Fuhr JP Jr (2012) Innovation and competition: will biosimilars succeed? Biotechnol Healthc 9(1):24–27